General Catalyst-backed Fay landed the Series B fundraise at a valuation around $500 million.

India's Ministry of Health posted an anti-obesity ad on X, featuring a silhouette resembling Winston Churchill, causing speculation and online debate.

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...